ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IONS Ionis Pharmaceuticals Inc

37.21
-2.00 (-5.10%)
Last Updated: 20:15:58
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ionis Pharmaceuticals Inc NASDAQ:IONS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -5.10% 37.21 37.20 37.22 39.22 36.75 39.00 2,272,524 20:15:58

Ionis to present at upcoming investor conferences

01/04/2024 12:05pm

PR Newswire (US)


Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart


From Mar 2024 to May 2024

Click Here for more Ionis Pharmaceuticals Charts.

CARLSBAD, Calif., April 1, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

Ionis logo (PRNewsfoto/Ionis Pharmaceuticals, Inc.)

  • 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 2024
  • 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024
  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024
  • 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionispharma.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has five marketed medicines and a leading pipeline in neurology, cardiology, and other areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionispharma.com and follow us on X (Twitter) and LinkedIn.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302102970.html

SOURCE Ionis Pharmaceuticals, Inc.

Copyright 2024 PR Newswire

1 Year Ionis Pharmaceuticals Chart

1 Year Ionis Pharmaceuticals Chart

1 Month Ionis Pharmaceuticals Chart

1 Month Ionis Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock